首页 | 本学科首页   官方微博 | 高级检索  
     

健脾抗癌方配合化疗治疗晚期大肠癌31例
引用本文:方志红,李雁,陈旻,陈东林. 健脾抗癌方配合化疗治疗晚期大肠癌31例[J]. 上海中医药杂志, 2009, 43(3): 29-31
作者姓名:方志红  李雁  陈旻  陈东林
作者单位:上海中医药大学附属市中医医院肿瘤科,上海,200071  
基金项目:上海申康医院发展中心中医肿瘤特色专科项目,上海市中医肿瘤临床优势专科项目 
摘    要:目的观察健脾抗癌方配合化疗治疗晚期大肠癌的临床疗效。方法将62例晚期大肠癌患者随机分为健脾抗癌方加化疗组(治疗组)和单纯化疗组(对照组)各31例,治疗2个月后观察两组临床疗效以及患者生活质量、3年生存率以及免疫、癌胚抗原(CEA)等指标的变化情况。结果治疗组和对照组总有效率分别为32.3%、29.0%,组间疗效比较,差异无统计学意义(P〉0.05);治疗组患者生活质量、免疫指标均较治疗前显著改善(P〈0.05),对照组治疗前后无显著差异(P〉0.05);两组癌胚抗原均较治疗前显著降低(P〈0.05),治疗后组间比较,差异有统计学意义(P〈0.05);治疗组生存率高于对照组(P〈0.05),不良反应发生率低于对照组(P〈0.05)。结论健脾抗癌方配合化疗对改善晚期大肠癌患者免疫功能、提高生活质量、延长生存期等方面有一定作用,并能减轻化疗不良反应。

关 键 词:肠癌  中西医结合疗法  健脾抗癌方

Clinical Observation of "Jianpi Kangai Decoction" and Chemotherapy for Advanced Large Intestine Cancer
FANG Zhi-hong LI Yan CHEN Min CHEN Dong-linTCM Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Clinical Observation of "Jianpi Kangai Decoction" and Chemotherapy for Advanced Large Intestine Cancer[J]. Shanghai Journal of Traditional Chinese Medicine, 2009, 43(3): 29-31
Authors:FANG Zhi-hong LI Yan CHEN Min CHEN Dong-linTCM Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Affiliation:(TCM Hospital Affiliated to Shanghai University of Traditional Chinese Medicine)
Abstract:Objective To observe the clinical effects of "Jianpi Kangai Decoction" combined with chemotherapy in treating advanced large intestine cancer.Methods Sixty-two subjects were randomized into two groups: treatment group in which 31 cases received "Jianpi Kangai Decoction" & chemotherapy and control group in which another 31 cases received chemotherapy alone.The clinical effects,quality of life,three-year survival rate,immune function and carcinoembryonic antigen(CEA) level in the two groups were observed.Resu...
Keywords:Large intestine cancer  integrative Chinese & western medicine  "  Jianpi Kangai Decoction"    
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号